253 results on '"McAlpine, Jessica N."'
Search Results
2. VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology
3. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
4. Single-cell genomic variation induced by mutational processes in cancer
5. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
6. Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
7. BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
8. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach
9. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
10. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome
11. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
12. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
13. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns
14. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status
15. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
16. From biobank and data silos into a data commons: convergence to support translational medicine
17. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
18. The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
19. Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
20. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
21. Abstract 223: Identifying gene amplifications in p53 abnormal endometrial carcinomas by shallow whole genome sequencing
22. Abstract 4542: Development of a one-step molecular classifier for endometrial carcinoma using an amplicon-based gene panel and next generation sequencing technology
23. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
24. p53-Abnormal “Fields of Dysplasia” in Human Papillomavirus–Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk
25. QPOLE:A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
26. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
27. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
28. The molecular origin and taxonomy of mucinous ovarian carcinoma
29. Determinants of Quality of Life in Ovarian Cancer Survivors: A Pilot Study
30. The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift
31. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
32. Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
33. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
34. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
35. Spatial expression of theFGFR2bsplice isoform and its prognostic significance in endometrioid endometrial carcinoma
36. Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma
37. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
38. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
39. Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis
40. Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention
41. Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma.
42. Additional file 1 of From biobank and data silos into a data commons: convergence to support translational medicine
43. FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes
44. The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
45. Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
46. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line
47. FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes
48. Fertility-sparing treatment in early endometrial cancer: current state and future strategies
49. Abstract B09: Single-cell RNA sequencing of normal endometrial organoids uncovers novel cell-type markers for prognostication of primary tumor samples
50. BRCA1Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.